Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane

Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Nuclear Medicine 2014-05, Vol.55 (5), p.765-771
Hauptverfasser: Chin, Bennett B., Kronauge, James F., Femia, Frank J., Chen, Jianqing, Maresca, Kevin P., Hillier, Shawn, Petry, Neil A., James, Olga G., Oldan, Jorge D., Armor, Thomas, Stubbs, James B., Stabin, Michael G., Babich, John W.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 771
container_issue 5
container_start_page 765
container_title Journal of Nuclear Medicine
container_volume 55
creator Chin, Bennett B.
Kronauge, James F.
Femia, Frank J.
Chen, Jianqing
Maresca, Kevin P.
Hillier, Shawn
Petry, Neil A.
James, Olga G.
Oldan, Jorge D.
Armor, Thomas
Stubbs, James B.
Stabin, Michael G.
Babich, John W.
description
doi_str_mv 10.2967/jnumed.113.124057
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_2967_jnumed_113_124057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2967_jnumed_113_124057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c907-c060d94d98dc12fbbf76703e03f62eb60fb7a870e0a4d0ae2713ad140b3dcf1d3</originalsourceid><addsrcrecordid>eNot0MFOAjEUheHGaCKiD-CuL1C8t51pZ5ZkIkpColFi3E067S2UDANpwYS3F4Ob8-_O4mPsEWEia22eNsNxS36CqCYoCyjNFRtJLGuhtfy-ZiNAjaIsobxldzlvAEBXVTViX-9rm0kgb_o4RGd7vkzxvB-Uj_0h813gr3G1Fp97cjFEJ6buEH_i4cQbm1KkJGaJiKNUfC7mu46G1dEOdM9ugu0zPfx3zJaz52XzKhZvL_NmuhCuBiMcaPB14evKO5Sh64LRBhSBClpSpyF0xlYGCGzhwZI0qKzHAjrlXUCvxgwvty7tck4U2n2KW5tOLUL759JeXNqzS3txUb-F8Vdh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Chin, Bennett B. ; Kronauge, James F. ; Femia, Frank J. ; Chen, Jianqing ; Maresca, Kevin P. ; Hillier, Shawn ; Petry, Neil A. ; James, Olga G. ; Oldan, Jorge D. ; Armor, Thomas ; Stubbs, James B. ; Stabin, Michael G. ; Babich, John W.</creator><creatorcontrib>Chin, Bennett B. ; Kronauge, James F. ; Femia, Frank J. ; Chen, Jianqing ; Maresca, Kevin P. ; Hillier, Shawn ; Petry, Neil A. ; James, Olga G. ; Oldan, Jorge D. ; Armor, Thomas ; Stubbs, James B. ; Stabin, Michael G. ; Babich, John W.</creatorcontrib><identifier>ISSN: 0161-5505</identifier><identifier>EISSN: 2159-662X</identifier><identifier>DOI: 10.2967/jnumed.113.124057</identifier><language>eng</language><ispartof>Journal of Nuclear Medicine, 2014-05, Vol.55 (5), p.765-771</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c907-c060d94d98dc12fbbf76703e03f62eb60fb7a870e0a4d0ae2713ad140b3dcf1d3</citedby><cites>FETCH-LOGICAL-c907-c060d94d98dc12fbbf76703e03f62eb60fb7a870e0a4d0ae2713ad140b3dcf1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Chin, Bennett B.</creatorcontrib><creatorcontrib>Kronauge, James F.</creatorcontrib><creatorcontrib>Femia, Frank J.</creatorcontrib><creatorcontrib>Chen, Jianqing</creatorcontrib><creatorcontrib>Maresca, Kevin P.</creatorcontrib><creatorcontrib>Hillier, Shawn</creatorcontrib><creatorcontrib>Petry, Neil A.</creatorcontrib><creatorcontrib>James, Olga G.</creatorcontrib><creatorcontrib>Oldan, Jorge D.</creatorcontrib><creatorcontrib>Armor, Thomas</creatorcontrib><creatorcontrib>Stubbs, James B.</creatorcontrib><creatorcontrib>Stabin, Michael G.</creatorcontrib><creatorcontrib>Babich, John W.</creatorcontrib><title>Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane</title><title>Journal of Nuclear Medicine</title><issn>0161-5505</issn><issn>2159-662X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNot0MFOAjEUheHGaCKiD-CuL1C8t51pZ5ZkIkpColFi3E067S2UDANpwYS3F4Ob8-_O4mPsEWEia22eNsNxS36CqCYoCyjNFRtJLGuhtfy-ZiNAjaIsobxldzlvAEBXVTViX-9rm0kgb_o4RGd7vkzxvB-Uj_0h813gr3G1Fp97cjFEJ6buEH_i4cQbm1KkJGaJiKNUfC7mu46G1dEOdM9ugu0zPfx3zJaz52XzKhZvL_NmuhCuBiMcaPB14evKO5Sh64LRBhSBClpSpyF0xlYGCGzhwZI0qKzHAjrlXUCvxgwvty7tck4U2n2KW5tOLUL759JeXNqzS3txUb-F8Vdh</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Chin, Bennett B.</creator><creator>Kronauge, James F.</creator><creator>Femia, Frank J.</creator><creator>Chen, Jianqing</creator><creator>Maresca, Kevin P.</creator><creator>Hillier, Shawn</creator><creator>Petry, Neil A.</creator><creator>James, Olga G.</creator><creator>Oldan, Jorge D.</creator><creator>Armor, Thomas</creator><creator>Stubbs, James B.</creator><creator>Stabin, Michael G.</creator><creator>Babich, John W.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201405</creationdate><title>Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane</title><author>Chin, Bennett B. ; Kronauge, James F. ; Femia, Frank J. ; Chen, Jianqing ; Maresca, Kevin P. ; Hillier, Shawn ; Petry, Neil A. ; James, Olga G. ; Oldan, Jorge D. ; Armor, Thomas ; Stubbs, James B. ; Stabin, Michael G. ; Babich, John W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c907-c060d94d98dc12fbbf76703e03f62eb60fb7a870e0a4d0ae2713ad140b3dcf1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chin, Bennett B.</creatorcontrib><creatorcontrib>Kronauge, James F.</creatorcontrib><creatorcontrib>Femia, Frank J.</creatorcontrib><creatorcontrib>Chen, Jianqing</creatorcontrib><creatorcontrib>Maresca, Kevin P.</creatorcontrib><creatorcontrib>Hillier, Shawn</creatorcontrib><creatorcontrib>Petry, Neil A.</creatorcontrib><creatorcontrib>James, Olga G.</creatorcontrib><creatorcontrib>Oldan, Jorge D.</creatorcontrib><creatorcontrib>Armor, Thomas</creatorcontrib><creatorcontrib>Stubbs, James B.</creatorcontrib><creatorcontrib>Stabin, Michael G.</creatorcontrib><creatorcontrib>Babich, John W.</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of Nuclear Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chin, Bennett B.</au><au>Kronauge, James F.</au><au>Femia, Frank J.</au><au>Chen, Jianqing</au><au>Maresca, Kevin P.</au><au>Hillier, Shawn</au><au>Petry, Neil A.</au><au>James, Olga G.</au><au>Oldan, Jorge D.</au><au>Armor, Thomas</au><au>Stubbs, James B.</au><au>Stabin, Michael G.</au><au>Babich, John W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane</atitle><jtitle>Journal of Nuclear Medicine</jtitle><date>2014-05</date><risdate>2014</risdate><volume>55</volume><issue>5</issue><spage>765</spage><epage>771</epage><pages>765-771</pages><issn>0161-5505</issn><eissn>2159-662X</eissn><doi>10.2967/jnumed.113.124057</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0161-5505
ispartof Journal of Nuclear Medicine, 2014-05, Vol.55 (5), p.765-771
issn 0161-5505
2159-662X
language eng
recordid cdi_crossref_primary_10_2967_jnumed_113_124057
source EZB-FREE-00999 freely available EZB journals
title Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T13%3A04%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase-1%20Clinical%20Trial%20Results%20of%20High-Specific-Activity%20Carrier-Free%20123%20I-Iobenguane&rft.jtitle=Journal%20of%20Nuclear%20Medicine&rft.au=Chin,%20Bennett%20B.&rft.date=2014-05&rft.volume=55&rft.issue=5&rft.spage=765&rft.epage=771&rft.pages=765-771&rft.issn=0161-5505&rft.eissn=2159-662X&rft_id=info:doi/10.2967/jnumed.113.124057&rft_dat=%3Ccrossref%3E10_2967_jnumed_113_124057%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true